TY - JOUR AU - López-Hernández, Juan Carlos AU - López-Alderete, Jorge AU - Angel , AU - Rosiles-Abonce, Artemio AU - Violante-Villanueva, Arturo AU - Gutiérrez-Romero, Alonso AU - Vargas-Cañas, Steven PY - 2022/05/26 Y2 - 2024/03/28 TI - GUILLAIN-BARRE SYNDROME RELATED TO THE APPLICATION OF VACCINE AGAINST SARS-CoV2 AND SEASONAL INFLUENZA. CASE REPORT JF - Archivos de Neurociencias JA - Arch Neurocien VL - 27 IS - 2 SE - Case report DO - 10.31157/an.v27i2.348 UR - https://archivosdeneurociencias.org/index.php/ADN/article/view/348 SP - 47-51 AB - <p><strong>Summary:</strong> Guillain Barre Syndrome (GBS) is the leading cause of acute flaccid paralysis in the world. In the course of the pandemic influenza virus in previous decades and, currently, SARS-CoV2, an increased number of GBS cases have been reported coinciding with mass vaccination. Recently, vaccination against these two viruses has been implemented in the vaccination schedules of the adult population. Objective: to report a case of GBS related to vaccination against seasonal influenza virus and SARS-CoV2. We present the case of a 53-year-old woman with no history of infectious disease, who, after vaccination against seasonal influenza and SARS-CoV2 (Oxford/AstraZeneca) within 22 days of each other, began with progressive symptoms of weakness predominantly in the lower limbs, ascending. Clinically, GBS was integrated. In the paraclinical studies, she had a lumbar puncture with albumin-cytological dissociation, with a neuroconduction study that fulfils the criteria for an AIDP variant. Conclusion: to our knowledge, this is the first case of GBS related to both types of vaccine.</p> ER -